Carregant...
The Cardiovascular Effects of Treatment with Hydroxychloroquine and Azithromycin
Hydroxychloroquine combined with azithromycin has been investigated for activity against coronavirus disease 2019 (COVID‐19), but concerns about adverse cardiovascular (CV) effects have been raised. This study evaluated claims data to determine if risks for CV events were increased with hydroxychlor...
Guardat en:
| Publicat a: | Pharmacotherapy |
|---|---|
| Autors principals: | , , , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
John Wiley and Sons Inc.
2020
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7404845/ https://ncbi.nlm.nih.gov/pubmed/32677113 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/phar.2445 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|